Bright Minds Biosciences (DRUG) Exchange Rate Effect (2020 - 2026)
Bright Minds Biosciences (DRUG) reported Exchange Rate Effect of $1.0 million for Q1 2026, up 8938.63% on a YoY basis from $11483.2 in Q1 2025, and up 200.82% quarter-over-quarter from -$1.0 million in Q4 2025.
Bright Minds Biosciences (DRUG) Exchange Rate Effect (2020 - 2026) Analysis & Trends
Bright Minds Biosciences has reported Exchange Rate Effect for 7 years, with the latest figure at $1.0 million in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect rose 8938.63% year-over-year to $1.0 million; the trailing twelve-month figure through Mar 2026 stood at -$932823.2 (down 177.98% YoY), and the FY2025 full-year result was $227164.3, up 2544.09% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at $1.0 million, up from -$1.0 million in the prior quarter.
- The five-year high for Exchange Rate Effect was $1.2 million in Q4 2024, with the low at -$1.0 million in Q4 2025.
- Historically, Exchange Rate Effect has averaged $14624.7 across 5 years, with a median of $3943.3 in 2023.
- Annual changes were most pronounced in 2025 — Exchange Rate Effect tumbled 3263.82% — and 2026, when it jumped 8938.63%.
- Bright Minds Biosciences' Exchange Rate Effect stood at $5193.0 in 2022, then plunged by 698.25% to -$31067.2 in 2023, then jumped by 3855.98% to $1.2 million in 2024, then tumbled by 188.23% to -$1.0 million in 2025, then jumped by 200.82% to $1.0 million in 2026.
- The last three Exchange Rate Effect figures came in at $1.0 million (Q1 2026), -$1.0 million (Q4 2025), and -$384416.1 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 8.68 Mn |
| 10 | Bright Minds Biosciences | 16.28 Bn | 16.22 Bn | - | 1.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.04 Mn |
| Mar 31, 2026 | 1.04 Mn |
| Dec 31, 2025 | -1.03 Mn |
| Dec 31, 2025 | -1.03 Mn |
| Sep 30, 2025 | -384,416.08 |
| Sep 30, 2025 | -384,416.08 |
| Jun 30, 2025 | -556,838.00 |
| Jun 30, 2025 | -556,838.00 |
| Mar 31, 2025 | -11,743.04 |
| Mar 31, 2025 | -11,743.04 |
| Dec 31, 2024 | 1.17 Mn |
| Dec 31, 2024 | 1.17 Mn |
| Sep 30, 2024 | 12,150.36 |
| Sep 30, 2024 | 12,150.36 |
| Jun 30, 2024 | 28,956.82 |
| Jun 30, 2024 | 28,956.82 |
| Mar 31, 2024 | -1,606.68 |
| Mar 31, 2024 | -1,606.68 |
| Dec 31, 2023 | -31,067.18 |
| Dec 31, 2023 | -31,067.18 |